|
|
|
Insider
Information: |
Nanavaty Maulik |
Relationship: |
|
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
177,758 |
|
Indirect Shares
|
11,017 |
|
|
Direct
Value |
$13,232,310 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
188,775 |
|
|
Total
Value |
$13,232,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
6.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2018-02-22 |
4 |
D |
$26.48 |
$17,265 |
D/D |
(652) |
227,452 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2017-08-30 |
4 |
S |
$27.08 |
$732,083 |
D/D |
(27,031) |
208,233 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2018-02-23 |
4 |
D |
$27.20 |
$21,842 |
D/D |
(803) |
228,488 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2018-02-24 |
4 |
D |
$27.20 |
$36,094 |
D/D |
(1,327) |
229,837 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2018-02-28 |
4 |
D |
$27.26 |
$67,768 |
D/D |
(2,486) |
232,363 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2017-08-31 |
4 |
S |
$27.45 |
$823,539 |
D/D |
(30,000) |
208,233 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-01-01 |
4 |
D |
$35.34 |
$138,992 |
D/D |
(3,933) |
240,168 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-01-15 |
4 |
AS |
$35.46 |
$107,727 |
D/D |
(3,038) |
240,168 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-01-01 |
4 |
D |
$35.95 |
$130,319 |
D/D |
(3,625) |
235,159 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-05-15 |
4 |
AS |
$36.74 |
$111,616 |
D/D |
(3,038) |
254,469 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2018-11-16 |
4 |
S |
$37.28 |
$874,446 |
D/D |
(23,458) |
233,351 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-02-28 |
4 |
D |
$37.39 |
$30,211 |
D/D |
(808) |
266,731 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-03-02 |
4 |
AS |
$37.47 |
$628,183 |
D/D |
(16,763) |
259,591 |
0 |
% |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-18 |
4 |
D |
$37.52 |
$23,075 |
D/D |
(615) |
241,645 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-04-15 |
4 |
AS |
$37.81 |
$114,905 |
D/D |
(3,039) |
254,469 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-21 |
4 |
D |
$38.03 |
$22,552 |
D/D |
(593) |
242,765 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-15 |
4 |
D |
$38.39 |
$22,074 |
D/D |
(575) |
240,482 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-28 |
4 |
D |
$38.78 |
$21,872 |
D/D |
(564) |
245,061 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-10 |
4 |
D |
$38.85 |
$87,024 |
D/D |
(2,240) |
239,396 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-22 |
4 |
D |
$39.20 |
$25,558 |
D/D |
(652) |
243,996 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-10-03 |
4 |
AS |
$39.25 |
$377,744 |
D/D |
(9,623) |
255,194 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-02-15 |
4 |
D |
$40.01 |
$23,006 |
D/D |
(575) |
244,293 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-02-20 |
4 |
D |
$40.11 |
$319,235 |
D/D |
(7,959) |
252,123 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-03-15 |
4 |
AS |
$40.11 |
$121,854 |
D/D |
(3,038) |
254,469 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-02-28 |
4 |
D |
$40.12 |
$32,417 |
D/D |
(808) |
254,469 |
0 |
- |
|
176 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|